Mereo BioPharma Group plc (MREO)

NASDAQ: MREO · Real-Time Price · USD

0.3860

-0.0009 (-0.23%)

At close: Mar 13, 2026, 4:00 PM EDT

0.3890

+0.0030 (0.78%)

After-hours: Mar 13, 2026, 7:49 PM EDT

Mereo BioPharma Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	48.7	69.8	57.41	68.15	127.49	32.09
Cash & Short-Term Investments	48.7	69.8	57.41	68.15	127.49	32.09
Cash Growth	-39.52%	21.57%	-15.76%	-46.54%	297.32%	48.02%
Accounts Receivable	-	-	3.32	0.92	1.92	1.39
Other Receivables	1.02	2.79	1.18	2.31	1.09	4.95
Total Trade Receivables	1.02	2.79	4.5	3.23	3.01	6.34
Other Current Assets	2.69	2.18	1.83	3.78	3.78	2.21
Total Current Assets	52.41	74.76	63.75	75.17	134.28	40.64
Net Property, Plant & Equipment	0.55	0.98	1.65	2.22	3.42	2.15
Other Intangible Assets	0.64	0.64	14.16	24.38	33.21	43.27
Total Assets	53.6	76.39	79.56	101.77	170.91	86.06
Accounts Payable	0.88	2.44	2.65	3.72	3.38	4.56
Accrued Expenses	4.12	4.07	5.46	5.43	5.17	5.71
Current Portion of Long-Term Debt	-	-	-	13.41	-	-
Current Portion of Leases	0.4	5.95	0.65	0.56	0.84	0.87
Other Current Liabilities	0.62	1.1	0.96	1.34	7.56	0.57
Total Current Liabilities	6.02	13.85	9.73	24.47	16.96	11.71
Long-Term Debt	-	-	4.99	-	19.45	22.07
Long-Term Leases	-	0.19	0.91	1.48	2.37	1.58
Other Long-Term Liabilities	0.99	1.39	1.17	0.16	13.16	71.17
Total Long-Term Liabilities	0.99	1.57	7.07	1.63	34.98	94.82
Total Liabilities	7	15.42	16.8	26.1	51.94	106.53
Common Stock	3.13	3.06	2.68	2.27	2.37	1.39
Treasury Stock	-	-	-1.24	-1.28	-1.54	-1.78
Additional Paid-in Capital	548.04	539.64	340.87	307.66	334.56	221.19
Accumulated Other Comprehensive Income	-10.91	-18.85	181.72	165.23	185.08	182.15
Retained Earnings	-493.67	-462.88	-461.26	-398.22	-401.5	-423.41
Shareholders' Equity	46.6	60.97	125.54	151.33	237.96	-40.94
Total Liabilities & Equity	53.6	76.39	142.33	177.43	289.89	65.59
Total Debt	0.4	6.14	6.54	15.45	22.66	24.52
Net Cash (Debt)	48.3	63.66	50.87	52.7	104.83	7.56
Net Cash Growth	-24.13%	25.14%	-3.47%	-49.73%	1285.75%	-
Net Cash Per Share	0.10	0.43	0.39	0.44	0.94	0.11
Book Value	46.6	60.97	125.54	151.33	237.96	-40.94
Book Value Per Share	0.10	0.41	0.95	1.25	2.14	-0.60
Tangible Book Value	45.96	60.33	111.37	126.94	204.75	-84.21
Tangible Book Value Per Share	0.10	0.41	0.84	1.05	1.84	-1.24

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q